eResearchTechnology and nSpire Health Deliver Integrated Cardiac Safety and Pulmonary Clinical Trial Services
eResearchTechnology and nSpire Health form alliance to benefit clinical researchers with cardio-pulmonary services.
Philadelphia, PA-April 14, 2008-eResearchTechnology, Inc. (eRT), (NASDAQ: ERES), and nSpire Health, Inc. announced today their alliance to provide integrated Cardiac Safety and Pulmonary Core Lab Services to clinical researchers worldwide.
eResearchTechnology is a leading provider of centralized electrocardiographic (ECG), eClinical technology, ePRO, and other services to the pharmaceutical, biotechnology, medical device, and related industries. nSpire Health is a leading provider of respiratory clinical trials services, including Cardiopulmonary Exercise Testing, High Definition Pulmonary Diagnostics Systems, Spirometry, and Home Monitoring.
Under the agreement, nSpire Health and eRT will deliver a combined solution to meet the increased demand for cardio-pulmonary safety and efficacy services during clinical trials, in part caused by an increased interest in using inhaled therapeutics. The partnership will offer integrated services from project planning and set-up through study conduct, management, and data delivery for primary and secondary Cardiac and Respiratory clinical trial endpoints. nSpire Health will provide eSP™ Core Lab Data Management software, QA services, HDpft™, KoKo®, PiKo®, and PiKoLogic™ (electronic Diary) respiratory diagnostic measuring instruments. eRT will perform digital collection, measurement, interpretation, review, and distribution of cardiac safety data through its EXPeRT 2.0 workflow-enabled data management system.
“This alliance addresses a growing need in clinical research to offer comprehensive, best in class services in these two closely related areas of clinical study,” said Michael McKelvey, president and chief executive officer of eRT. “While many sponsors recognize and source each company for its respective area of expertise, customers increasingly seek consolidation and streamlining in all phases of a clinical trial. eRT and nSpire Health approach the market in the same way-focusing on scientific excellence, providing a quality product, and client satisfaction. We are both metrics driven and process oriented to ensure on-time, on-budget, reliable data delivery on a global scale.”
“Clinical trial sponsors have a strategic need to deliver accurate, cost-effective results in less time. They need therapeutic specialists that they can trust. This partnership leverages the world’s most advanced Cardio-Respiratory specific technologies and data management services from each company into one unified source, reducing costs and accelerating time to market for emerging inhaled therapeutic trials,” commented Michael S. Sims, president and chief executive officer of nSpire Health, Inc.
About nSpire Health
nSpire Health ( www.nspirehealth.com) develops and manufactures respiratory care products and provides related services in over 100 countries. The company is focused on cardiopulmonary diagnostics, respiratory core lab services, and disease management solutions designed to improve health care productivity while increasing the overall quality of patient care. nSpire Health is the exclusive provider of PiKo home health monitors and HDpft systems, the most accurate and precise pulmonary function testing systems worldwide.
About eRT
Based in Philadelphia, PA, eResearchTechnology, Inc. ( www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis and distribution of clinical data in all phases of clinical development.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
